Sleep apnea is clinically recognized as a heterogeneous group of disorders characterized by recurrent apnea and/or hypopnea. Its prevalence ranges from 4% to 24%. It has been implicated as an independent risk factor for several conditions such as hypertension, stroke, arrhythmia, and myocardial infarction. Recently data has been emerging which suggests an independent association of obstructive sleep apnea with several components of the metabolic syndrome, particularly insulin resistance and abnormalities in lipid metabolism. We hereby review the salient features of the association between sleep and diabetes
Obstructive sleep apnoea (OSA) is increasingly recognised as a risk factor for cardiometabolic dysfu...
Sleep profoundly affects metabolic pathways. In healthy subjects, experimental sleep restriction cau...
BACKGROUND: Obstructive sleep apnoea syndrome (OSAS) is a risk factor for type 2 diabetes mellitus (...
Obstructive sleep apnea (OSA) and type 2 diabetes are both closely related to obesity and their prev...
Metabolic syndrome (MS), the commonly used term for the clustering of obesity, insulin resistance, h...
Obstructive sleep apnea (OSA) is prevalent with type 2 diabetes. Conversely, nondiabetic patients wi...
Obstructive sleep apnea (OSA) is prevalent with type 2 diabetes. Conversely, nondiabetic patients wi...
It has been observed in clinical practice and confirmed through epide-miologic and clinic-based stud...
This review explores the relation between obstructive sleep apnoea syndrome (OSAS) and diabetes. It ...
This review explores the relation between obstructive sleep apnoea syndrome (OSAS) and diabetes. It ...
This review explores the relation between obstructive sleep apnoea syndrome (OSAS) and diabetes. It ...
This review explores the relation between obstructive sleep apnoea syndrome (OSAS) and diabetes. It ...
Epidemiological studies have implicated obstructive sleep apnea (OSA) as an independent comorbid fac...
Abstract Obstructive sleep apnoea (OSA) is a cardio-metabolic disorder. Whether metabolic syndrome (...
The sleep state itself has modulatory effects on glucose homeostasis. Epidemiologic and experimental...
Obstructive sleep apnoea (OSA) is increasingly recognised as a risk factor for cardiometabolic dysfu...
Sleep profoundly affects metabolic pathways. In healthy subjects, experimental sleep restriction cau...
BACKGROUND: Obstructive sleep apnoea syndrome (OSAS) is a risk factor for type 2 diabetes mellitus (...
Obstructive sleep apnea (OSA) and type 2 diabetes are both closely related to obesity and their prev...
Metabolic syndrome (MS), the commonly used term for the clustering of obesity, insulin resistance, h...
Obstructive sleep apnea (OSA) is prevalent with type 2 diabetes. Conversely, nondiabetic patients wi...
Obstructive sleep apnea (OSA) is prevalent with type 2 diabetes. Conversely, nondiabetic patients wi...
It has been observed in clinical practice and confirmed through epide-miologic and clinic-based stud...
This review explores the relation between obstructive sleep apnoea syndrome (OSAS) and diabetes. It ...
This review explores the relation between obstructive sleep apnoea syndrome (OSAS) and diabetes. It ...
This review explores the relation between obstructive sleep apnoea syndrome (OSAS) and diabetes. It ...
This review explores the relation between obstructive sleep apnoea syndrome (OSAS) and diabetes. It ...
Epidemiological studies have implicated obstructive sleep apnea (OSA) as an independent comorbid fac...
Abstract Obstructive sleep apnoea (OSA) is a cardio-metabolic disorder. Whether metabolic syndrome (...
The sleep state itself has modulatory effects on glucose homeostasis. Epidemiologic and experimental...
Obstructive sleep apnoea (OSA) is increasingly recognised as a risk factor for cardiometabolic dysfu...
Sleep profoundly affects metabolic pathways. In healthy subjects, experimental sleep restriction cau...
BACKGROUND: Obstructive sleep apnoea syndrome (OSAS) is a risk factor for type 2 diabetes mellitus (...